Citation

  • Authors: Wang, Y. C., Wang, J. L., Kong, X., Sun, T. T., Chen, H. Y., Hong, J., Fang, J. Y.
  • Year: 2014
  • Journal: Apoptosis 19 643-56
  • Applications: in vivo / siRNA / in vivo-jetPEI

Method

siRNA was complexed with in vivo-jetPEI in a total volume of 30µl and injected into subcutaneous tumors (MGC803 cells) of nude mice (10µl injected at 3 different points). Injections were repeated every 2 days for 24 days.

Abstract

The development of gastric cancer (GC) is a complex multistep process, including numerous genetic and epigenetic changes. CD24 is associated with enhanced invasiveness of GC and a poor prognosis. However, the mechanism by which CD24 induces GC progression remains poorly characterized. Here, we found that the expression of CD24 gradually increased in samples of normal gastric mucosa, non-atrophic chronic gastritis, chronic atrophic gastritis (CAG), CAG with intestinal metaplasia, dysplasia and GC. Moreover, the knockdown of CD24 induced significant levels of apoptosis in GC cells via the mitochondrial apoptotic pathway. CD24 may also promote cellular invasion and regulate the expression of E-cadherin, fibronectin and vitamin D receptor in GC cells. The activation of signal transducer and activator of transcription 3 (STAT3) may mediate CD24-induced GC survival and invasion in vitro. Furthermore, CD24-induced GC progression and STAT3 activation could also be detected in vivo and in clinical GC tissues samples. Taken together, our results indicate that CD24 mediates gastric carcinogenesis and may promote GC progression by suppressing apoptosis and promoting invasion, with the activation of STAT3 playing a critical role.

Pubmed